Announcements Trials
Browse Landscape

Phase

Phase 4 8Phase NA 3Phase 3 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Genitourinary 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Prostatic Neoplasms 1Obesity 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Sugammadex × Clear all
NCT04854993 2023-01-25

RECIR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Completed
34 enrolled
Genitourinary

Prostatic Neoplasms

NCT03196791 2021-07-12

Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient

Korea University Anam Hospital

Phase 3 Completed
196 enrolled 11 charts
GastrointestinalOther

Obesity, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡